Neuroblastoma is a relatively radiosensitive tumour, but because of its tendency to early dissemination, local radiotherapy alone is rarely curative. Biologically targeted radiotherapy is an alternative therapeutic strategy which exploits tissue specific differences to enable relatively selective delivery of radionuclides to tumour deposits. One way of targeting neuroblastoma utilises biochemical mechanisms which preferentially accumulate catecholamines, their precursors and analogues such as metaiodobenzyl guanidine (mIBG) (Smets et al., 1989; Paffenholz et al., 1989) . This approach has met with some therapeutic success (Vofite et al., 1987) but its optimal role in patient management has yet to be defined. Clearly a laboratory model for further investigation of targeted radiotherapy of neuroblastoma with mIBG would be valuable.
The cytogenetic, immunological and molecular biological properties of the human neuroblastoma cell line NB1-G have been extensively studied (Carachi et al., 1987) . The response of this line to irradiation has been investigated in detail (Wheldon et al., 1985 (Wheldon et al., , 1986 (Wheldon et al., , 1987 . The ability of NB1-G to grow as multicellular tumour spheroids has enabled its use as an in vitro model of biologically targeted radiotherapy using monoclonal antibodies (Walker et al., 1988) , although these do not penetrate the centre of spheroids as readily as mIBG . The aim of this study was to define the pharmacokinetics of mIBG uptake and retention by NBI-G, and to investigate their modification by other drugs.
Cells were seeded into sixwell plates at an initial density of 5 x 105 per well. They were cultured as monolayers for 3 or 4 days at 37°C in 5% CO2 in Eagle's Minimal Essential Medium containing 25 mM Hepes buffer, 10% foetal calf serum, 2 mM glutamine, penicillin/streptomycin (100 IU ml-') and amphotericin B (2.5pgml-'). All In retention studies, the monolayers were washed twice after incubation with '311-mIBG. Warm mIBG-free medium with or without reserpine, verapamil or nifedipine was then added and the activity remaining in the cells was measured at various time intervals.
Comparison was made with two other neuroblastoma cell lines, SK-N-SH (Biedler et al., 1973) and IMR-32 (Tumilowicz et al., 1970) , SK-N-SH accumulates mIBG by the specific active uptake-l mechanism (Buck et al., 1985; Smets et al., 1989) , whereas IMR-32 does not (Buck et al., 1985) .
The concentration dependency of mIBG uptake by the three lines following 2h incubations at 37°C, is shown in Figure 1 . Compared with the high affinity and saturability of SK-N-SH uptake, IMR-32 demonstrated low level incorporation which increased linearly with increasing mIBG concentration. Accumulation of mIBG by NBI-G was greater than that of IMR-32 but less than that of SK-N-SH at all concentrations of the drug up to 2 itM. The rate of uptake of 0.1 M mIBG by NB1-G at 37°C is shown in Figure 2 , and also indicates the saturability of the mechanism. When incubations were conducted at 4°C, uptake was negligible ( Figure  3a) . (Figure 3b ). Ouabain is a specific inhibitor of sodium-potassium-dependent ATP-ase transport mechanisms. Preincubation of NBI-G cells with 1 mM ouabain reduced the uptake of 0. Use of sodium-free medium reduced uptake of 0.1 ;M mIBG to 63% (Figure 3d ). While the uptake of 0.1I1M mIBG from both glucose-free medium, and medium containing 2-deoxy-glucose was not significantly different following 30 min preincubation, uptake was reduced to 54% with glucose-free medium, and 46% with 2-deoxy-glucose when the preincubation time was extended to 18 h. Use of 1.5 mM sodium dithionite effectively abolished active uptake, reducing total uptake to only 17% of the control value ( Figure  3e ).
The incorporation of 0.1 -I M '311-mIBG into NB1-G monolayers was reduced to 21% of control values by 1 mM (i.e. 104-fold molar excess) L-norepinephrine (Figure 3f ). This is similar to the inhibitory effects of 1 mM ouabain and 1.51 M desmethylimipramine on 0.1 L M mIBG uptake. Therefore passive accumulation by NB1-G cells accounts for about 20% of total uptake of 0.1I M mIBG.
No modification of uptake of 0.1 L M mIBG by NB1-G cells was seen in the presence of verapamil, nifedipine or reserpine.
Retention of mIBG after uptake by NB1-G cells was limited. Most of the accumulated radiopharmaceutical quickly left the cells with only about 20% retained after 3 to 4 h (Figure 4 ). Reserpine had a short lived and modest effect on mIBG retention. At 2 h, cells incubated with 10 L M reserpine after uptake of mIBG retained 37% more than controls incubated with medium alone. At longer times and with lower concentrations of reserpine, the amounts retained were comparable with controls. Similarly cells incubated with 20 p M verapamil after uptake of mIBG retained 32% more than controls. Again by 3 to 4 h, the retained amounts were similar for both treated and control cells. Nifedipine at concentrations of 10-100 ;L M had no discernable effect on egress of mIBG from NB1-G cells.
These results indicate that the human neuroblastoma cell line NB1-G shows active uptake (uptake-i) of mIBG, similar to that seen in adrenal medullary cells (Jaques et al., 1984) , phaeochromocytoma cells (Jaques et al., 1987) and in other neuroblastoma lines (Smets et al., 1989; Paffenholz et al., 1989) . This process is saturable, and is temperature, sodium and oxygen dependent. It can be blocked by specific inhibitors of sodium-potassium-dependent ATP-ase transport mechanisms such as ouabain and by monoamine reuptake inhibitors such as desmethylimipramine. Catecholamines such as norepinephrine which are taken up by the same pathway will competitively block uptake if present in excess. At the low concentrations of mIBG ( <0.2 iL M) which exist in vivo during imaging and therapy (Smets et al., 1991) , the uptake-I mechanism is predominant.
Since mIBG taken up in this way is rapidly lost from the cells, any drug which modifies release may be therapeutically useful. Blake et al., (1988) I II retention of mIBG due to nifedipine in one of five patients undergoing treatment for phaeochromocytoma. Although nifedipine does not appear to affect mIBG kinetics in NB1-G, our demonstration that verapamil prolongs mIBG retention in this cell line is worthy of further investigation, although the concentrations used were in excess of the plasma levels of about 1-2 IL M achieved in clinical practice. The site of intracellular storage of mIBG in the neuroblastoma cell line SK-N-SH is thought to be predominantly extravesicular (Smets et al., 1989) . Our finding that reserpine, which prevents catecholamine storage in neurosecretory granules, does not promote loss of mIBG from NB1-G, is compatible with the observation that the majority of mIBG taken up by this line is stored in the mitochondria .
We conclude that NB1-G is a suitable cell line for in vitro studies of the targeted radiotherapy of human neuroblastoma with mIBG. This work was supported by the Cancer Research Campaign, grant number SP 1866.
